About the Award
The Controlled Release Society Transdermal Delivery Kydonieus Foundation Award recognizes CRS members who have made outstanding contributions to the field of transdermal delivery science and technology over a minimum of five (5) years. Contributions may have been technical, scientific, and/or managerial in the field of transdermal delivery commercial development, education, and/or leadership within the areas of interest to CRS.
Criteria
- Nominee must be an established investigator who has made an outstanding innovative contribution in the area of transdermal delivery.
- Nominees for the award may be from academia, industry, or government and may be representative of all demographic groups.
- Nominees must be a current CRS member.
Service and leadership within CRS will be considered, but is not a requirement for the receiving of Transdermal Delivery Kydonieus Foundation Award
Nominations - Closed
All nominations for the primary CRS awards are submitted through the same form for consideration. Please note, that self-nominations are greatly encouraged. The following areas will be reviewed for eligibility by the Award Committee:
- Contributions to Drug Delivery Science (50%)
- Contributions to the Controlled Release Society (30%)
- Contributions to Equality, Diversity and Inclusion (20%)
- A CV for the nominee is required
Nomination period: January 15, 2024 – March 15, 2024 11:59 pm ET.
Selection Process
The Transdermal Kydonieus Award Committee will make the selection of the awardee. The committee is comprised of a Chair selected by the CRS Awards Board Liaison, 1 previous winner, 1 College of Fellows member, and 1 Skin and Mucosal (previously Transdermal and Mucosal) Focus Group past Chair.
Award
- Award Plaque presented at the Annual Meeting
- $3,000 USD Honorarium presented at the Annual Meeting